HBeAg阴性慢性乙型肝炎的中医治疗研究进展  

Research Progress in the Treatment of HBeAg Negative Chronic Hepatitis B with Traditional Chinese Medici

作　　者：覃武海 黎裕朝 张荣臻[2] 

机构地区：[1]玉林市中医医院,广西玉林537000 [2]广西中医药大学第一附属医院,广西南宁530023

出　　处：《大众科技》2023年第9期50-53,共4页Popular Science & Technology

摘　　要：慢性乙型肝炎(Chronic hepatitis B,CHB)由乙型肝炎病毒(Hepatitis B Virus,HBV)感染所致,可发展至肝纤维化、肝硬化、肝癌,严重威胁患者健康,给患者和社会带来沉重的负担。HBV感染呈世界性流行,现代医学尚未有治愈的药物,在防治其并发症的发生,特别是抑制肝纤维化发生和进展方面的研究具有重要意义。近年来中医药被发现在治疗HBeAg阴性CHB方面有独特优势。文章整理总结了HBeAg阴性CHB的病因病机、中医辨证论治等方面的研究进展,以期为HBeAg阴性CHB的临床治疗提供借鉴和参考。Chronic hepatitis B(CHB)is caused by hepatitis B virus(HBV)infection,which can develop into liver fibrosis,cirrhosis,and liver cancer,posing a serious threat to patients'health and bringing heavy burden to patients and society.HBV infection is prevalent worldwide,and there is no cure in modern medicine.It is of great significance in the prevention and treatment of its complications,especially in inhibiting the occurrence and progress of liver fibrosis.In recent years,traditional Chinese medicine has been found to have unique advantages in the treatment of HBeAg-negative CHB.The article summarizes the research progress in the etiology,pathogenesis,traditional Chinese medicine differentiation and treatment of HBeAg negative CHB,in order to provide reference for the clinical treatment of HBeAg negative CHB.

关 键 词：中医药 HBEAG阴性慢性乙型肝炎 研究进展 

分 类 号：R51[医药卫生—内科学] R37[医药卫生—临床医学]